Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2025

Mar 6, 2025

34491_dirs_2025-03-05_b3b08044-6380-4c7a-b429-f62053818662.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2025-03-03

Reporting Person: Kelly John Alexander (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-03 Common Stock M 1702 Acquired 86256 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-03 Restricted Stock Units $ M 1702 Disposed Common Stock (1702) Direct

Footnotes

F1: Represents the vesting of Restricted Stock Units ("RSUs") on March 3, 2025.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: On March 3, 2022, the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025.